ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

0.47
Delayed Data
As of May 22
 -0.015 / -3.09%
Today’s Change
0.43
Today|||52-Week Range
1.45
-35.62%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for ImmunoCellular Therapeutics Ltd have a median target of 3.00, with a high estimate of 3.00 and a low estimate of 3.00. The median estimate represents a +538.30% increase from the last price of 0.47.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in ImmunoCellular Therapeutics Ltd. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.02
Sales
$0.00
Reporting Date
May 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 33.33%
 
 
 
 
 
 
Growthannually -9.68%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account